CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 34 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $8,000 | +60.0% | 1,114 | +50.5% | 0.00% | – |
| Q2 2017 | $5,000 | 0.0% | 740 | +10.1% | 0.00% | – |
| Q1 2017 | $5,000 | +25.0% | 672 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | 0.0% | 672 | -24.8% | 0.00% | – |
| Q3 2016 | $4,000 | 0.0% | 894 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | +33.3% | 894 | +33.0% | 0.00% | – |
| Q1 2016 | $3,000 | -25.0% | 672 | 0.0% | 0.00% | – |
| Q4 2015 | $4,000 | 0.0% | 672 | 0.0% | 0.00% | – |
| Q3 2015 | $4,000 | -20.0% | 672 | 0.0% | 0.00% | – |
| Q2 2015 | $5,000 | +25.0% | 672 | 0.0% | 0.00% | – |
| Q1 2015 | $4,000 | 0.0% | 672 | 0.0% | 0.00% | – |
| Q4 2014 | $4,000 | +33.3% | 672 | 0.0% | 0.00% | – |
| Q3 2014 | $3,000 | -40.0% | 672 | -34.6% | 0.00% | – |
| Q2 2014 | $5,000 | 0.0% | 1,028 | 0.0% | 0.00% | – |
| Q1 2014 | $5,000 | +66.7% | 1,028 | +53.0% | 0.00% | – |
| Q4 2013 | $3,000 | 0.0% | 672 | 0.0% | 0.00% | – |
| Q3 2013 | $3,000 | 0.0% | 672 | 0.0% | 0.00% | – |
| Q2 2013 | $3,000 | – | 672 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,109,167 | $7,764,000 | 4.19% |
| JW Asset Management, LLC | 263,881 | $1,847,000 | 1.18% |
| BARD ASSOCIATES INC | 88,515 | $620,000 | 0.28% |
| Ariel Investments | 976,377 | $6,835,000 | 0.08% |
| TFS CAPITAL LLC | 20,896 | $146,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 293,700 | $2,076,000 | 0.02% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 15,959 | $112,000 | 0.02% |
| DELTA ASSET MANAGEMENT LLC/TN | 12,000 | $84,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 52,767 | $369,000 | 0.01% |
| Spark Investment Management LLC | 20,300 | $142,000 | 0.01% |